Tag: Prescription Drugs
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
Rising costs of oral, injectable generic and specialty drugs mostly driven by new product entry
No Increased Fall Risk With HTN Treatment in Older Women
Lower incidence rate ratios found for women with treated controlled hypertension, treated uncontrolled HTN
Exercise Can Consistently Lower Blood Pressure
Reductions in BP from exercise comparable but not as great as from medications
Gabapentin Improves Sexual Function in Provoked Vulvodynia
Sexual function improved for gabapentin vs. placebo, but still lower than among matched pain-free controls
Multimethod Approach Improves ID of Med Nonadherence
Use of provider report, medication possession ratio improved ID of nonadherence in youth with CKD
Rituximab Beneficial in Secondary Progressive MS
Treatment with rituximab linked to lower Expanded Disability Status Scale score, delayed progression
Prenatal Valproate Exposure Linked to Increased ADHD Risk
Maternal use of other antiepileptic drugs not tied to increased ADHD risk
Price of Alirocumab Would Have to Be Cut to Be Cost-Effective
Price of alirocumab would have to decrease from original cost of $14,560 to $1,974 to be cost-effective
No Increased Fracture Risk With Canagliflozin in Type 2 Diabetes
Rate of the primary outcome was similar for canagliflozin, glucagon-like peptide-1 agonist
Available Vial Sizes Can Cut Drug Waste in Weight-Based Dosing
Vial preparation sizes can be optimized to reduce drug wastage, reduce costs
